Researchers at the University of Queensland are making significant strides toward developing a groundbreaking topical cream to prevent and treat skin cancers, specifically in organ transplant ...

The use of an investigational topical BRAF-inhibiting gel appeared to be effective in treating acneiform rash in patients ...

A new topical ... cancer commonly are treated with anti‐EGFR therapies, such as cetuximab and panitumumab. However, EGFR inhibition blocks the MAPK pathway, disrupting normal skin cell function ...

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center have demonstrated that a novel topical ... in the skin that anti-EGFR ...

LUT014 works by paradoxically reactivating MAPK, a key signaling pathway in the skin that anti-EGFR therapies shut down.

Is it true you should use estrogen cream on your face to protect ... While research suggests topical estrogen products may help improve skin dryness, texture and elasticity in menopausal women ...

A novel topical formulation ... at MD Anderson Cancer Center, Houston, explained the scientific rationale behind investigating the use of LUT014 to mitigate skin rash caused by anti-EGFR therapies.

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center have demonstrated that a novel topical ... in the skin that anti-EGFR ...

UCLA researchers demonstrated that a novel topical BRAF inhibitor gel called LUT014 significantly reduces the severity of an acne-like rash, a common and painful side effect experienced by patients ...

Novel treatment allowed patients with colorectal cancer to successfully continue taking their cancer treatment with improved quality of life. Acne-like skin rash is a common side effect from ...